跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BROXILEX - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
BROXILEX
Approved
STANDARD
BROXILEX
Lloyd Laboratores, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
27862446b78726a0
Company
Lloyd Laboratores, Inc.
Type
Standard
Approval Details
Approval Id
27862446b78726a0
Drug Approval Philippines Name
BROXILEX
Product Name
BROXILEX
Registration Number
DRP-2061
Brand Name
BROXILEX
Generic Name
Ambroxol Hydrochloride
Dosage Form
Tablet
Dosage Strength
30 mg
Manufacturer
Lloyd Laboratores, Inc.
Trader
Interhealthcare Pharmaceuticals, Inc.
Distributor
Medirich Pharma Distribution Corp.
Issuance Date
27 September 2021
Expiry Date
28 October 2026
Pharmacologic Category
Mucolytic
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
27862446b78726a0
Type
Standard
Back to Philippines FDA Approvals